| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4238720 | Journal of Vascular and Interventional Radiology | 2014 | 5 Pages |
Abstract
Transcatheter hepatic arterial administration of irinotecan-loaded drug-eluting beads (DEBIRI) is used to treat liver-only or liver-dominant metastatic disease from colorectal cancer (CRC). Eligibility for DEBIRI should be established in each individual patient by a multidisciplinary team based on comprehensive clinical, imaging, and laboratory assessment. Standardization of DEBIRI technique and protocols would be expected to lead to improved efficacy and safety. The present article provides a set of technical recommendations for the use of DEBIRI in the treatment of hepatic CRC metastases.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Riccardo MD, Camillo MD, Thierry MD, Ricardo MD, Govindarajan MD, Elizabeth MD, William S. MD, Duncan MD, Robert C.G. MD,